The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ADU-1604, a novel CTLA-4 blocking antibody, to modulate pharmacodynamic markers in patients with PD1 relapse/refractory melanoma.
 
Guillermo De Velasco
Honoraria - Astellas Pharma; BMSi; Ipsen; Pfizer
Consulting or Advisory Role - Astellas Medivation; Bayer; BMSi; Ipsen; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Research Funding - Ipsen
Travel, Accommodations, Expenses - BMSi; Roche
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Philogen; Pierre Fabre
Speakers' Bureau - Novartis; Pfizer; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre
 
Anna Maria Di Giacomo
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Immunocore; Immunocore; MSD Oncology; Pierre Fabre; Sanofi; Sun Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre
 
Ana Maria Arance
Consulting or Advisory Role - BioNTech SE; BMS; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - BMS; MSD; Novartis; Pierre Fabre; Roche
Research Funding - BioNTech SE (Inst); BMS (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; MSD
 
Caroline Robert
Stock and Other Ownership Interests - RiboNexus
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Sun Pharma
Research Funding - Novartis (Inst); Phio Pharmaceuticals (Inst)
 
Vanna Chiarion-Sileni
Consulting or Advisory Role - Immunocore; Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre; Sanofi
 
Ivan Marquez-Rodas
Consulting or Advisory Role - Amgen; AstraZeneca; Bioncotech; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi; Sun Pharma
Travel, Accommodations, Expenses - Bioncotech; Bristol-Myers Squibb; MSD; Pierre Fabre; Roche; Sun Pharma
 
Jessica Kundapur
Employment - Sairopa
 
Julien Villaudy
Consulting or Advisory Role - Sairopa
 
Hans van Eenennaam
Employment - Sairopa
Leadership - Sairopa
Stock and Other Ownership Interests - Sairopa
Honoraria - Sairopa
Consulting or Advisory Role - Catalym
Patents, Royalties, Other Intellectual Property - Sairopa
Travel, Accommodations, Expenses - Sairopa
 
Laura Lassouw-Polman
Employment - Sairopa
Leadership - Sairopa
Stock and Other Ownership Interests - Sairopa
 
Alexander M. Eggermont
Stock and Other Ownership Interests - IO Biotech; Sairopa; Skyline Diagnostics
Honoraria - Agenus; BIOINVENT; BioNTech; BioNTech.; Brenus Pharma; CatalYm; Ellipses Pharma; GenOway; GlaxoSmithKline; IO Biotech; IQVIA; ISA Pharmaceuticals; Merck; MSD; Pfizer; Pierre Fabre; Sairopa; Scorpion Therapeutics; Sellas Life Sciences; Skyline Diagnostics; TigaTx; Trained Therapeutix Discovery
Consulting or Advisory Role - Agenus; BIOINVENT; BioNTech.; BioNTech.; Brenus Pharma; CatalYm; Ellipses Pharma; GenOway; GlaxoSmithKline; IO Biotech; IQVIA; ISA Pharmaceuticals; Merck; MSD; Pfizer; Pierre Fabre; Sairopa; Scorpion Therapeutics; Sellas Life Sciences; Skyline Diagnostics; TigaTx; Trained Therapeutix Discovery
Speakers' Bureau - Bristol-Myers Squibb.; Merck; MSD